What is the share price of Narmada Bio-Chem Ltd?

Company share prices are keep on changing according to the market conditions. The current trading price of Narmada Bio-Chem Ltd on 01-Jan-1970 05:30:00 at 05:30 is .

What is the P/E ratio of Narmada Bio-Chem?

The latest standalone P/E ratio of Narmada Bio-Chem as of 01-Jan-1970 is 0.00.

What is the P/B ratio of Narmada Bio-Chem Ltd?

The latest standalone P/B ratio of Narmada Bio-Chem Ltd as of 01-Jan-1970 is 0.00.

What is the 52-week high and low of Narmada Bio-Chem Ltd?

The 52-week high of Narmada Bio-Chem Ltd is Rs. 0.00 and the 52-week low is Rs. 0.00.

Narmada Bio-Chem Ltd Share Analysis – Quality, Valuation Zone & Price Trend & DeciZen Rating

Name: Narmada Bio-Chem Ltd
Brand: Narmada Bio-Chem

Narmada Bio-Chem Ltd

Share Analysis – Quality, Valuation Zone, Price Trend & DeciZen Rating BSE: 0 NSE: Fertilizers | Small Cap | Narmada Bio-Chem Share Price

Narmada Bio-Chem Ltd

Share Analysis – Quality, Valuation Zone, Price Trend & DeciZen Rating BSE: 0 NSE: Fertilizers | Small Cap | Narmada Bio-Chem Share Price

Key Metrics

Valuation Multiples

Market Cap

₹0 Cr.

Current Price

₹0

52-Week Low / High

₹0 / 0

TTM EPS

₹14.9

TTM Sales

₹172 Cr.

Book Value per Share

₹105.2

P/E Ratio

0.00

Industry PE

14.5

Price to Book (P/B)

0.00

Price to Sales (P/S)

0.00

EV/EBITDA

0.00

Dividend Yield

0.00%

Profitability Efficiency

Return on Equity (ROE)

12.90%

Return on Capital Employed (ROCE)

15.56%

Return on Assets (ROA)

6.29%

Operating Profit Margin

15%

Net Profit Margin

7.17%

Gross Profit Margin

12.4%

Growth Momentum
1-yr vs 3-yr growth

Sales Growth (1 Year)

Slowing versus 3-year growth rate

-1.26%

Operating Profit Growth (1 Year)

Improving versus 3-year growth rate

37.9%

Net Profit Growth (1 Year)

Improving versus 3-year growth rate

63.13%

Asset Quality

Promoter Holding

99.44%

Pledged shares (%) of Promoter's holding (%)

0.00%

Reserves

₹86 Cr.

Equity

₹8.2 Cr.

Face Value

₹1

All Time Low / High

- / -

10 Year X-Ray :

Analysis of Financial Track Record (Data adjusted to bonus, split, extra-ordinary income, rights issue and change in financial year end)

Data adjusted to bonus, split, extra-ordinary income, rights issue and change in financial year end

Value Creation ⓘ

	Mar'14	Mar'15	Mar'16	Mar'17	Mar'18	TTM
ROCE % ⓘ	19.7%	22%	24.9%	13%	15.6%	-
Value Creation Index ⓘ	0.4	0.6	0.8	-0.1	0.1	-
Growth Parameters ⓘ
Sales ⓘ	151	176	227	174	172	172
Sales YoY Gr.	-	17%	29%	-23.6%	-1.3%	-
Adj EPS ⓘ	0.6	0.7	8.7	4.8	7.7	14.9
YoY Gr.	-	28.1%	1089%	-44.7%	60.8%	-
BVPS (₹) ⓘ	0	4.4	51.9	56.7	64.5	105.2
Adj Net Profit ⓘ	9	11.5	13.7	7.6	12.2	123
Cash Flow from Ops. ⓘ	-2.3	11.7	9.8	-14.1	9.2	-
Debt/CF from Ops. ⓘ	-11.7	2.5	3.5	-3.8	6.3	-

CAGR ⓘ

	9 Years	5 Years	3 Years	1 Years
Sales ⓘ	NA	NA	-0.9%	-1.3%
Adj EPS ⓘ	NA	NA	119.5%	60.8%
BVPSⓘ	NA	NA	145.5%	13.8%
Share Price	-	-	-	-

Key Financial Parameters ⓘ

	Mar'14	Mar'15	Mar'16	Mar'17	Mar'18	TTM
Return on Equity % ⓘ	15.2	17.9	18.2	8.8	12.8	17.6
Op. Profit Mgn % ⓘ	14.3	14	12.7	10.8	15	NAN
Net Profit Mgn % ⓘ	6	6.5	6	4.4	7.1	71.7
Debt to Equity ⓘ	0.5	0.4	0.4	0.6	0.6	-
Working Cap Days ⓘ	0	162	172	293	314	0
Cash Conv. Cycle ⓘ	0	77	64	124	178	0

Profit And Loss

(All Figures are in Crores.)

PARTICULARS	Mar'14	Mar'15	Mar'16	Mar'17	Mar'18
Sales	150.74	176.32	227.43	173.74	171.55
Operating Expenses ⓘ +	130.04	151.96	199.42	155.11	145.86
Manufacturing Costs	27.85	27.57	19.69	21.24	27.25
Material Costs	91.65	111.37	167.45	121.64	104.23
Employee Cost	4.27	5.63	6.04	6.41	7.36
Other Costs ⓘ	6.27	7.40	6.24	5.82	7.02
Operating Profit ⓘ	20.71	24.36	28.01	18.63	25.69
Operating Profit Margin (%)	13.7%	13.8%	12.3%	10.7%	15.0%
Other Income ⓘ +	0.41	0.83	2.57	1.91	1.69
Exceptional Items ⓘ	0	0	0	0	0
Interest ⓘ	4.93	4.30	7.15	6.40	6.14
Depreciation ⓘ	3.48	4.48	4	3.81	3.92
Profit Before Tax ⓘ	12.71	16.41	19.43	10.32	17.32
Tax ⓘ	4.26	5.18	6.38	2.78	5.02
Profit After Tax	8.44	11.22	13.05	7.54	12.30
PAT Margin (%)	5.6%	6.4%	5.7%	4.3%	7.2%
Adjusted EPS (₹)	0.0	0.7	8.3	4.8	7.8
Dividend Payout Ratio (%)	0%	0%	0%	0%	0%

Valuation of Narmada Bio-Chem - Standalone

YTD 1Y 3Y 5Y 10Y Max

Analyst's Notes

No data found!

Balance Sheet

(All Figures are in Crores.)

PARTICULARS	Mar'14	Mar'15	Mar'16	Mar'17	Mar'18
Equity and Liabilities
Shareholders Fund +	57.34	68.54	81.66	89.20	101.52
Share Capital ⓘ	15.73	15.73	15.74	15.74	15.74
Reserves ⓘ	41.61	52.81	65.92	73.46	85.78
Debt +	27.35	26.80	33.93	52.93	55.62
Long Term Debt	4.79	1.39	0.55	0.45	6.57
Short Term Debt	22.56	25.41	33.38	52.48	49.05
Minority Interest	0	0	0	0	0
Trade Payables	13.99	19.51	49.15	40.81	15.52
Others Liabilities ⓘ	17.81	17.56	16.33	13.52	22.11
Total Liabilities ⓘ	116.48	132.41	181.07	196.47	194.77
Fixed Assets
Net Fixed Assets ⓘ +	42.60	42.58	40.87	43.10	48.24
Gross Block	46.04	50.50	52.54	58.58	67.58
Accumulated Depreciation	3.45	7.93	11.67	15.48	19.34
CWIP ⓘ	1.02	0.03	0.80	0.57	0
Investments ⓘ	0.45	1.95	0.45	1.30	1.36
Inventories	33.84	31.23	50.89	51.18	57.64
Trade Receivables	18.29	30.11	47.09	67.28	58.46
Cash Equivalents	0.90	2.16	9.18	0.65	0.97
Others Assets ⓘ	19.39	24.37	31.80	32.39	28.09
Total Assets ⓘ	116.48	132.41	181.07	196.47	194.77

Cash Flow

(All Figures are in Crores.)

PARTICULARS	Mar'14	Mar'15	Mar'16	Mar'17	Mar'18
Cash Flow From Operating Activity ⓘ +	-2.34	11.71	9.82	-14.13	9.21
PBT ⓘ	12.71	16.41	19.43	10.32	17.32
Adjustment ⓘ	8.74	8.74	11.12	9.09	9.76
Changes in Working Capital ⓘ	-18.92	-9.98	-15.38	-27.28	-17.35
Tax Paid ⓘ	-4.87	-3.46	-5.36	-6.26	-0.53
Cash Flow From Investing Activity ⓘ +	-3.64	-4.76	-2.21	-4.41	-7.80
Capex	-3.91	-3.56	-4.15	-4.02	-7.97
Net Investments	0	-1.50	1.52	-0.80	0
Others ⓘ	0.27	0.30	0.43	0.41	0.17
Cash Flow From Financing Activity ⓘ +	-1.50	-6.89	-2.38	13.15	-1.33
Net Proceeds from Shares ⓘ	10.50	0	0.05	0	0
Net Proceeds from Borrowing ⓘ	-32.05	-3.39	-3.60	-0.09	8.19
Interest Paid ⓘ	-4.71	-4.15	-6.80	-5.86	-6.09
Dividend Paid ⓘ	0	0	0	0	0
Others ⓘ	24.76	0.65	7.97	19.10	-3.43
Net Cash Flow ⓘ	-7.48	0.06	5.23	-5.39	0.09

Financial Ratio

PARTICULARS	Mar'14	Mar'15	Mar'16	Mar'17	Mar'18
Ratios
ROE (%)	14.73	17.83	17.38	8.82	12.9
ROCE (%)	19.66	22.04	24.86	12.97	15.56
Asset Turnover Ratio	1.3	1.43	1.46	0.92	0.88
PAT to CFO Conversion(x)	-0.28	1.04	0.75	-1.87	0.75
Working Capital Days
Receivable Days	43.90	49.80	61.70	119.60	133.70
Inventory Days	81.30	66.90	65.70	106.80	115.70
Payable Days	55.70	54.90	74.80	135	98.60

Management X-Ray

Shareholding Pattern

Promoter's Holding & Share Pledging

Pledged ^*

0.00

* Pledged shares as % of Promoter's holding (%)

Top 5 Mutual Funds Holding

Last Visited Stocks

Announcements

Narmada Bio-Chem Ltd FAQs

The current trading price of Narmada Bio-Chem on 01-Jan-1970 05:30 is ₹0.00.

Market capitalization or market cap is determined by multiplying the current market price of a company's shares with the total number of shares outstanding. As of 31-Dec-1969 the market cap of Narmada Bio-Chem stood at ₹0.00 Cr

The latest P/E ratio of Narmada Bio-Chem as of 31-Dec-1969 is 0.00.

The latest P/B ratio of Narmada Bio-Chem as of 31-Dec-1969 is 0.00.

The 52-week high of Narmada Bio-Chem is ₹0.00 and the 52-week low is ₹0.00.

The TTM revenue is Trailing Twelve Months sales. The TTM revenue/sales of Narmada Bio-Chem is ₹172 ( Cr.) .

Data is not available for this company.

No data found

About Narmada Bio-Chem Ltd

No data to display

Narmada Bio-Chem Ltd

Narmada Bio-Chem Ltd

10 Year X-Ray :